The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy
Open accessAbstract
Purpose: Prior results of breast-conserving therapy (BCT) have shown substantial rates of local recurrence (LR) in young patients with breast cancer (BC). Patients and Methods: We studied 1,434 consecutive patients with invasive BC who received BCT from December 1997 to July 2006. Ninety-one percent received adjuvant systemic therapy; no patients received trastuzumab. Five BC subtypes were approximated: estrogen receptor (ER) or progesterone receptor (PR) positive, HER2 negative, and grades 1 to 2 (ie, luminal A); ER positive or PR positive, HER2 negative, and grade 3 (ie, luminal B); ER or PR positive, and HER2 positive (ie, luminal HER2); ER negative, PR negative, and HER2 positive (ie, HER2); and ER negative, PR negative, and HER2 negative (ie, triple negative). Actuarial rates of LR were calculated by using the Kaplan-Meier method. Results: Median follow-up was 85 months. Overall 5-year cumulative incidence of LR was 2.1% (95% CI, 1.4% to 3.0%). The 5-year cumulative incidence of LR was 5.0% (95% CI, 3.0% to 8.3%) for age quartile 23 to 46 years; 2.2% (95% CI, 1.0% to 4.6%) for ages 47 to 54 years; 0.9% (95% CI, 0.3% to 2.6%) for ages 55 to 63 years; and 0.6% (95% CI, 0.1% to 2.2%) for ages 64 to 88 years. The 5-year cumulative incidence of LR was 0.8% (95% CI, 0.4% to 1.8%) for luminal A; 2.3% (95% CI, 0.8% to 5.9%) for luminal B; 1.1% (95% CI, 0.2% 7.4%) for luminal HER2; 10.8% (95% CI, 4.6% to 24.4%) for HER2; and 6.7% (95% CI, 3.6% to 12.2%) for triple negative. On multivariable analysis, increasing age was associated with decreased risk of LR (adjusted hazard ratio, 0.97; 95% CI, 0.94 to 0.99; P = .009). Conclusion: In the era of systemic therapy and BC subtyping, age remains an independent prognostic factor after BCT. However, the risk of LR for young women appears acceptably low.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
(1968) · American Association of Industrial Nurses Journal · doi:10.1177/216507996801601208 · Cited by 8,798
Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., Jeong, J.-H., & Wolmark, N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa022152 · Cited by 6,249
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
Veronesi, U., Cascinelli, N., Mariani, L., Greco, M., Saccozzi, R., Luini, A., Aguilar, M., & Marubini, E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020989 · Cited by 4,450
Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,836
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Cheang, M. C. U., Chia, S. K., Voduc, D., Gao, D., Leung, S., Snider, J., Watson, M., Davies, S., Bernard, P. S., Parker, J. S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp082 · Cited by 2,249
Fisher, B., Bauer, M., Margolese, R., Poisson, R., Pilch, Y., Redmond, C., Fisher, E., Wolmark, N., Deutsch, M., Montague, E., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503143121101 · Cited by 2,194
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Rouzier, R., Perou, C. M., Symmans, W. F., Ibrahim, N., Cristofanilli, M., Anderson, K., Hess, K. R., Stec, J., Ayers, M., Wagner, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2421 · Cited by 1,891
Fisher, B., Redmond, C., Poisson, R., Margolese, R., Wolmark, N., Wickerham, L., Fisher, E., Deutsch, M., Caplan, R., Pilch, Y., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903303201302 · Cited by 1,587
van Dongen, J. A. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1143 · Cited by 1,271
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
Voduc, K. D., Cheang, M. C. U., Tyldesley, S., Gelmon, K., Nielsen, T. O., & Kennecke, H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9284 · Cited by 1,243
Anders, C. K., Hsu, D. S., Broadwater, G., Acharya, C. R., Foekens, J. A., Zhang, Y., Wang, Y., Marcom, P. K., Marks, J. R., Febbo, P. G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2471 · Cited by 911
Jacobson, J. A., Danforth, D. N., Cowan, K. H., d'Angelo, T., Steinberg, S. M., Pierce, L., Lippman, M. E., Lichter, A. S., Glatstein, E., & Okunieff, P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321402 · Cited by 892
Nguyen, P. L., Taghian, A. G., Katz, M. S., Niemierko, A., Abi Raad, R. F., Boon, W. L., Bellon, J. R., Wong, J. S., Smith, B. L., & Harris, J. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4287 · Cited by 811
Self-citationFisher, B., Bryant, J., Dignam, J. J., Wickerham, D. L., Mamounas, E. P., Fisher, E. R., Margolese, R. G., Nesbitt, L., Paik, S., Pisansky, T. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.101 · Cited by 667
Fisher, B., Dignam, J., Bryant, J., & Wolmark, N. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.684 · Cited by 635
Nixon, A. J., Neuberg, D., Hayes, D. F., Gelman, R., Connolly, J. L., Schnitt, S., Abner, A., Recht, A., Vicini, F., & Harris, J. R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.888 · Cited by 579
Self-citationVoogd, A. C., Nielsen, M., Peterse, J. L., Blichert-Toft, M., Bartelink, H., Overgaard, M., van Tienhoven, G., Andersen, K. W., Sylvester, R. J., van Dongen, J. A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1688 · Cited by 562
Anderson, S. J., Wapnir, I., Dignam, J. J., Fisher, B., Mamounas, E. P., Jeong, J.-H., Geyer, C. E., Wickerham, D. L., Costantino, J. P., & Wolmark, N. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8424 · Cited by 458
Clarke, D. H., G. Lê, M., Sarrazin, D., Lacombe, M.-J., Fontaine, F., Travagli, J.-P., May-Levin, F., Contesso, G., & Arriagada, R. (1985) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(85)90372-4 · Cited by 408
Blichert-Toft, M., Rose, C., Andersen, J. A., Overgaard, M., Axelsson, C. K., Andersen, K. W., & Mouridsen, H. T. (1992) · PubMed · Cited by 371
Estrogen-Regulated Genes Predict Survival in Hormone Receptor–Positive Breast Cancers
Oh, D. S., Troester, M. A., Usary, J., Hu, Z., He, X., Fan, C., Wu, J., Carey, L. A., & Perou, C. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2755 · Cited by 356
van Dongen, J. A., Bartelink, H., Fentiman, I. S., Lerut, T., Mignolet, F., Olthuis, G., van der Schueren, E., Sylvester, R., Tong, D., Winter, J., et al. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90118-l · Cited by 268
FISHER, E. R., Anderson, S., Redmond, C. K., & Fisher, B. (1992) · PubMed · Cited by 268
Breast cancer outcome and predictors of outcome: are there age differentials?
Albain, K. S., Allred, D. C., & Clark, G. M. (1994) · PubMed · Cited by 264
Anders, C. K., Fan, C., Parker, J. S., Carey, L. A., Blackwell, K. L., Klauber-DeMore, N., & Perou, C. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9199 · Cited by 263
Young age: an independent risk factor for disease-free survival in women with operable breast cancer
Han, W., Kim, S. W., Ae Park, I., Kang, D., Kim, S.-W., Youn, Y.-K., Oh, S. K., Choe, K. J., & Noh, D.-Y. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-82 · Cited by 259
Why are local recurrences after breast-conserving therapy more frequent in younger patients?
Kurtz, J. M., Jacquemier, J., Amalric, R., Brandone, H., Ayme, Y., Hans, D., Bressac, C., & Spitalier, J. M. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.4.591 · Cited by 258
The influence of young age on outcome in early stage breast cancer
Fowble, B. L., Schultz, D. J., Overmoyer, B., Solin, L. J., Fox, K., Jardines, L., Orel, S., & Glick, J. H. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90515-0 · Cited by 241
Elkhuizen M.D., P. H. M., van de Vijver M.D., P. D., Hermans Ph.D., J., Zonderland M.D., H. M., van de Velde M.D., P. D., & Leer M.D., P. D. (1998) · International Journal of Radiation OncologyBiologyPhysics · doi:10.1016/s0360-3016(97)00917-6 · Cited by 237
Boyages, J., Recht, A., Connolly, J. L., Schnitt, S. J., Gelman, R., Kooy, H., Love, S., Osteen, R. T., Cady, B., Silver, B., et al. (1990) · Radiotherapy and Oncology · doi:10.1016/0167-8140(90)90163-q · Cited by 224
Self-citationTrihia, H., Murray, S., Price, K., Gelber, R. D., Golouh, R., Goldhirsch, A., Coates, A. S., Collins, J., Castiglione‐Gertsch, M., & Gusterson, B. A. (2003) · Cancer · doi:10.1002/cncr.11188 · Cited by 189
Spyratos, F., Ferrero‐Poüs, M., Trassard, M., Hacène, K., Phillips, E., Tubiana‐Hulin, M., & Le Doussal, V. (2002) · Cancer · doi:10.1002/cncr.10458 · Cited by 186
Stotter, A. T., McNeese, M. D., Ames, F. C., Oswald, M. J., & Ellerbroek, N. A. (1989) · Cancer · Cited by 181
Vrieling, C., Collette, L., Fourquet, A., Hoogenraad, W. J., Horiot, J.-C., Jager, J. J., Bing Oei, S., Peterse, H. L., Pierart, M., Poortmans, P. M., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00123-0 · Cited by 175
Leong, C., Boyages, J., Jayasinghe, U. W., Bilous, M., Ung, O., Chua, B. H., Salisbury, E., & Wong, A. Y. (2004) · Cancer · doi:10.1002/cncr.20153 · Cited by 154
Kroman, N. T., Holtveg, H., Wohlfahrt, J., Jensen, M., Mouridsen, H. T., Blichert-Toft, M., & Melbye, M. (2004) · Cancer · doi:10.1002/cncr.20022 · Cited by 146
Swanson, G. M., & Lin, C. S. (1994) · PubMed · Cited by 139
Bollet, M. A., Sigal‐Zafrani, B., Mazeau, V., Savignoni, A., de la Rochefordière, A., Vincent‐Salomon, A., Salmon, R. J., Campana, F., Kirova, Y., Dendale, R., et al. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.01.001 · Cited by 138
Molecular Classification of Breast Carcinomas by Immunohistochemical Analysis: Are We Ready?
Tang, P., Skinner, K. A., & Hicks, D. G. (2009) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e31818d107b · Cited by 128
Improving local control with breast‐conserving therapy
Cabıoğlu, N., Hunt, K. K., Buchholz, T. A., Mirza, N. Q., Singletary, S. E., Kuerer, H. M., Babiera, G. V., Ames, F. C., Şahin, A. A., & Meric‐Bernstam, F. (2005) · Cancer · doi:10.1002/cncr.21121 · Cited by 105
Tumor Biology of Breast Cancer in Young Women
Klauber‐DeMore, N. (2006) · Breast Disease · doi:10.3233/bd-2006-23103 · Cited by 83
Is Mastectomy Superior to Breast-Conserving Treatment for Young Women?
Coulombe, G., Tyldesley, S. K., Speers, C. H., Paltiel, C., Aquino‐Parsons, C., Bernstein, V., Truong, P. T., Keyes, M., & Olivotto, I. A. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.032 · Cited by 75
Pass, H. A., Vicini, F. A., Kestin, L. L., Goldstein, N. S., Decker, D. A., Pettinga, J., Ingold, J. A., Benitez, P., Neumann, K., Rebner, M., et al. (2004) · Cancer · doi:10.1002/cncr.20410 · Cited by 55
White, J. R., Halberg, F. E., Rabinovitch, R. A., Green, S., Haffty, B. G., Solin, L. J., Strom, E. A., Taylor, M. E., & Edge, S. B. (2008) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2008.02.026 · Cited by 29
McCormick, B. L. (1994) · Cancer · doi:10.1002/cncr.2820741331 · Cited by 20
Cited by
Moran, M. S., Schnitt, S. J., Giuliano, A. E., Harris, J. R., Khan, S. A., Horton, J., Klimberg, S., Chavez-MacGregor, M., Freedman, G., Houssami, N., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3481-4 · Cited by 612
Self-citationIs early-onset cancer an emerging global epidemic? Current evidence and future implications
Ugai, T., Sasamoto, N., Lee, H.-Y., Ando, M., Song, M., Tamimi, R. M., Kawachi, I., Campbell, P. T., Giovannucci, E. L., Weiderpass, E., et al. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00672-8 · Cited by 603
Houssami, N., Macaskill, P., Luke Marinovich, M., & Morrow, M. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3480-5 · Cited by 532
Moran, M. S., Schnitt, S. J., Giuliano, A. E., Harris, J. R., Khan, S. A., Horton, J., Klimberg, S., Chavez-MacGregor, M., Freedman, G., Houssami, N., et al. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.11.012 · Cited by 495
Self-citationSubtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
Partridge, A. H., Hughes, M. E., Warner, E. T., Ottesen, R. A., Wong, Y.-N., Edge, S. B., Theriault, R. L., Blayney, D. W., Niland, J. C., Winer, E. P., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.8013 · Cited by 473
Metadata
- Authors
- Arvold, N. D., Taghian, A. G., Niemierko, A., Abi Raad, R. F., Sreedhara, M., Nguyen, P. L., Bellon, J. R., Wong, J. S., Smith, B. L., & Harris, J. R.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-10-10
- Volume
- 29
- Issue
- 29
- Pages
- 3885-3891
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2115603976
- Cited by
- 452
- References
- 54
- FWCI
- 9.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.